Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Marianna Valzano"'
Autor:
Ilaria Morelli, Carlotta Becherini, Marco Banini, Marianna Valzano, Niccolò Bertini, Mauro Loi, Giulio Francolini, Icro Meattini, Viola Salvestrini, Pierluigi Bonomo, Lorenzo Livi, Isacco Desideri
Publikováno v:
Applied Sciences, Vol 13, Iss 23, p 12942 (2023)
Background: Oropharyngeal Squamous Cell Carcinoma (OPSCC) is rapidly increasing due to the spread of Human Papillomavirus (HPV) infection. HPV-positive disease has unique characteristics, with better response to treatment and consequent better progno
Externí odkaz:
https://doaj.org/article/e4198cd12a014323a5a9c2d90a673275
Autor:
Mauro Loi, Giulia Salvatore, Michele Aquilano, Daniela Greto, Cinzia Talamonti, Viola Salvestrini, Maria Elena Melica, Marianna Valzano, Giulio Francolini, Mariangela Sottili, Costanza Santini, Carlotta Becherini, Domenico Andrea Campanacci, Monica Mangoni, Lorenzo Livi
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 22, p 14305 (2022)
Trabectedin is used for the treatment of advanced soft tissue sarcomas (STSs). In this study, we evaluated if trabectedin could enhance the efficacy of irradiation (IR) by increasing the intrinsic cell radiosensitivity and modulating tumor micro-envi
Externí odkaz:
https://doaj.org/article/04fbe55788a8433a94004161c664547c
Autor:
Giulio Francolini, Michele Ganovelli, Vanessa Di Cataldo, Beatrice Detti, Saverio Caini, Mauro Loi, Gabriele Simontacchi, Isacco Desideri, Daniela Greto, Marianna Valzano, Sergio Serni, Luca Vaggelli, Viola Salvestrini, Luca Visani, Carlotta Becherini, Emanuela Olmetto, Ciro Franzese, Davide Baldaccini, Marta Scorsetti, Martina Sollini, Arturo Chiti, Icro Meattini, Richard K. Valicenti, Lorenzo Livi
Publikováno v:
Clinical & experimental metastasis, vol 40, iss 2
PSICHE (NCT05022914) is a prospective trial to test a [68Ga]Ga- PSMA-11 PET/CT imaging tailored strategy. All evaluable patients had biochemical relapse after surgery and underwent centralized [68Ga]Ga-PSMA-11 PET/CT imaging. The treatment was perfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7c07e7fda156e6f3e519604bf13d958
https://escholarship.org/uc/item/26c8w6z0
https://escholarship.org/uc/item/26c8w6z0
Autor:
Giulio Francolini, Vanessa Di Cataldo, Beatrice Detti, Gabriele Simontacchi, Mauro Loi, Marianna Valzano, Isacco Desideri, Icro Meattini, Monica Mangoni, Lorenzo Livi
Publikováno v:
Clinical & Experimental Metastasis. 39:841-843
Recent findings confirmed benefit from metastasis-directed therapy in oligometastatic hormone sensitive prostate cancer (omHSPC). However, current landscape of systemic treatment suggests that patients could benefit, at the same time, from early init
Autor:
Giulio Francolini, Pietro Garlatti, Vanessa Di Cataldo, Beatrice Detti, Mauro Loi, Daniela Greto, Gabriele Simontacchi, Ilaria Morelli, Luca Burchini, Andrea Gaetano Allegra, Giulio Frosini, Michele Ganovelli, Viola Salvestrini, Emanuela Olmetto, Luca Visani, Carlotta Becherini, Marianna Valzano, Maria Grazia Carnevale, Manuele Roghi, Sergio Serni, Chiara Mattioli, Isacco Desideri, Lorenzo Livi
Publikováno v:
Cancers; Volume 15; Issue 3; Pages: 992
Biochemical recurrences after radical prostatectomy (RP) can be managed with curative purpose through salvage radiation therapy (SRT). RT dose escalation, such as stereotactic RT (SSRT), may improve relapse-free survival in this setting. STARR trial
Autor:
Carlotta Becherini, Isacco Desideri, Sofia Cherici, Serena Pancani, Giovanna Alpigiano, Viola Salvestrini, Marianna Valzano, Erika Scoccimarro, Carolina Orsatti, Anna Peruzzi, Lorenzo Livi, Pierluigi Bonomo
PurposeExpected weight loss and discontinuation of the planned therapeutic program plays a key role in oncological care and treatment effectiveness in Head-Neck Cancer (HNC) patients.We aimed to determine the impact of dietary counselling in a prospe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::624614bf51ff25d2af2220b540159e7d
https://doi.org/10.21203/rs.3.rs-2027803/v1
https://doi.org/10.21203/rs.3.rs-2027803/v1
Autor:
Giulio Francolini, Mauro Loi, Lucia Pia Ciccone, Beatrice Detti, Vanessa Di Cataldo, Pamela Pinzani, Francesca Salvianti, Giulia Salvatore, Mariangela Sottili, Costanza Santini, Giulio Frosini, Luca Visani, Luca Burchini, Chiara Mattioli, Andrea Gaetano Allegra, Marianna Valzano, Cecilia Cerbai, Michele Aquilano, Viola Salvestrini, Isacco Desideri, Monica Mangoni, Icro Meattini, Lorenzo Livi
Publikováno v:
Medical Oncology. 39
Circulating tumor cells detection and ARV7 expression are associated with worse clinical outcomes in metastatic Castration-Resistant Prostate Cancer (mCRPC) undergoing Androgen Receptor Targeted Agents. ARFL, PSMA and PSA may help to refine prognosti
Autor:
Luca Visani, Lorenzo Livi, Ivica Ratosa, Miha Orazem, Domen Ribnikar, Calogero Saieva, Carlotta Becherini, Viola Salvestrini, Erika Scoccimarro, Marianna Valzano, Cecilia Cerbai, Isacco Desideri, Marco Bernini, Lorenzo Orzalesi, Jacopo Nori, Simonetta Bianchi, Andrea Morandi, Icro Meattini
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 177
Cyclin-dependent kinase 4/6 inhibitors (CDK4/6i) currently represent the standard of care for the initial treatment of patients with metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer. The
Autor:
Isacco Desideri, Sara Lucidi, Giulio Francolini, Icro Meattini, Lucia Pia Ciccone, Viola Salvestrini, Marianna Valzano, Ilaria Morelli, Lucia Angelini, Vieri Scotti, Pierluigi Bonomo, Daniela Greto, Francesca Terziani, Carlotta Becherini, Luca Visani, Lorenzo Livi
Context Aromatase Inhibitors (AIs) are recommended for the adjuvant treatment of hormone receptor positive breast cancer in both high-risk pre-menopausal and post-menopausal population; arthralgia is the main cause of discontinuation of therapy and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0cda9a730cd03a475786b104b69892a
https://doi.org/10.21203/rs.3.rs-1367222/v1
https://doi.org/10.21203/rs.3.rs-1367222/v1
Autor:
Giulio Francolini, Arun Ghoshal, Saverio Caini, Tessa Piazzini, Carlotta Becherini, Beatrice Detti, Vanessa Di Cataldo, Marianna Valzano, Michele Ganovelli, Andrea Gaetano Allegra, Giulio Frosini, Luca Burchini, Luca Visani, Viola Salvestrini, Emanuela Olmetto, Mauro Loi, Gabriele Simontacchi, Isacco Desideri, Icro Meattini, Lorenzo Livi
Publikováno v:
Journal of Clinical Oncology. 41:489-489
489 Background: Radical cystectomy (RC) with or without perioperative chemotherapy is considered the standard treatment option for Muscle invasive bladder cancer (MIBC), despite poor oncological outcomes. However, RC is often burdened by significant